Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment

Seminars in Nephrology

Volumn 27, Issue 2, 2007, Pages 153-160

  Zhu, Yanqing ^a   Usui, Hitomi Kataoka ^a   Sharma, Kumar ^a  

^a Department of Medicine   (United States)

Author keywords

decorin; glucose excursion; HETE; macrophages; podocytes; Protein kinase C; reactive oxygen species; thrombospondin; upstream stimulatory factor

Indexed keywords

DECORIN; GLUCOSE; HEXOSAMINE; LATENCY ASSOCIATED PEPTIDE; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; UPSTREAM STIMULATORY FACTOR;

ARTICLE; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; MACROPHAGE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

ANIMALS; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; PROGNOSIS; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 34147159558     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.01.008     Document Type: Article

References (88)

1. Sharma K., and Ziyadeh F. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17 (1997) 80-92
2. McGowan T., Zhu Y., and Sharma K. Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy. Curr Diabetes Rep 4 (2004) 447-454
3. McGowan T.A., Dunn S.R., Falkner B., and Sharma K. Stimulation of urinary TGF-{beta} and isoprostanes in response to hyperglycemia in humans. Clin J Am Soc Nephrol 1 (2006) 263-268
4. Whiteside C., and Dlugosz J.A. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol 282 (2002) F975-F980
5. Studer R.K., Craven P.A., and DeRubertis F.R. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high glucose medium. Diabetes 42 (1993) 118-126
6. Lee T.S., Saltsman K.A., Ohashi H., and King G.L. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A 86 (1989) 5141-5145
7. Koya D., Jirousek M., Lin Y., Ishii H., Kuboki K., and King G. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100 (1997) 115-126
8. Koya D., Haneda M., Nakagawa H., Isshiki K., Sato H., Maeda S., et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14 (2000) 439-447
9. Tuttle K.R., Bakris G.L., Toto R.D., McGill J.B., Hu K., and Anderson P.W. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28 (2005) 2686-2690
10. Menne J., Park J.-K., Boehne M., Elger M., Lindschau C., Kirsch T., et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase c-{alpha}--deficient diabetic mice. Diabetes 53 (2004) 2101-2109
11. Hua H., Munk S., Goldberg H., Fantus I.G., and Whiteside C.I. High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J Biol Chem 278 (2003) 33951-33962
12. Iglesias-De La Cruz M.C., Ruiz-Torres P., Alcami J., Diez-Marques L., Ortega-Velazquez R., Chen S., et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59 (2001) 87-95
13. Nath K.A., Grande J., Croatt A., Haugen J., Kim Y., and Rosenberg M.E. Redox regulation of renal DNA synthesis, transforming growth factor-[bgr]1 and collagen gene expression. Kidney Int 53 (1998) 367
14. Melhem M.C., Liachenko J., and DeRubertis F.R. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13 (2002) 108-116
15. DeRubertis F., Craven P., Melhem M., and Salah E. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53 (2004) 762-768
16. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280 (2005) 39616-39626
17. Thannickal V.J., and Fanburg B.L. Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor B1*. J Biol Chem 270 (1995) 30334-30338
18. Hu T., Ramachandrarao S.P., Siva S., Valancius C., Zhu Y., Mahadev K., et al. Reactive oxygen species production via NADPH oxidase mediates TGF-{beta}-induced cytoskeletal alterations in endothelial cells. Am J Physiol 289 (2005) F816-F825
19. Sharma K., Cook A., Smith M., Valancius C., and Inscho E.W. TGF-{beta} impairs renal autoregulation via generation of ROS. Am J Physiol 288 (2005) F1069-F1077
20. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128 (1992) 117-131
21. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11 (1997) 851-857
22. Reddy M., Adler S.G., Kim Y.S., Lanting L., Rossi J., Kang S.W., et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol 283 (2002) F985-F994
23. Kim Y.-S., Xu Z.-G., Reddy M.A., Li S.-L., Lanting L., Sharma K., et al. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol 16 (2005) 352-362
24. Nerlich A., Sauer U., Kolm-Litty V., Wagner E., Koch M., Schleicher E.D., et al. Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47 (1998) 170-178
25. Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., and Schleicher E. High glucose-induced transforming growth factor-β1 production is mediated by the hexosamine pathway in procine glomerular mesangial cells. J Clin Invest 101 (1998) 160-169
26. Burt D., Gruden G., Thomas S.M., Tutt P., Dell'Anna C., Viberti G.C., et al. p38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 46 (2003) 531-537
27. Haneda M., Koya D., and Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 38 Suppl 1 (2001) S178-S181
28. Kang H.S., Adler S., LaPage J., and Natarajan R. p38 MAPK and MAPK kinase 3/6 mRNA mRNA and activities are increased in early diabetic glomeruli. Kidney Int 60 (2001) 543-552
29. Feliers D., Duraisamy S., Faulkner J.L., Duch J., Lee A.V., Abboud H., et al. Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int 60 (2001) 495-504
30. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., and Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46 (1997) 847-853
31. Adhikary L., Chow II F., Nikolic-Paterson D.J., Stambe C., Dowling J., Atkins R.C., et al. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 47 (2004) 1210-1222
32. Zhang M., Fraser D., and Phillips A. ERK, p38, and smad signaling pathways differentially regulate transforming growth factor-{beta}1 autoinduction in proximal tubular epithelial cells. Am J Pathol 169 (2006) 1282-1293
33. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275 (2000) 17728-17739
34. Wilmer W., Dixon C., and Herbert C. Chronic exposure to high glucose environment activates the p38 MAPK pathway. Kidney Int 60 (2001) 858-871
35. Kuki S., Imanishi T., Kobayashi K., Matsuo Y., Obana M., and Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen activated protein kinase. Circulation J 70 (2006) 1076-1081
36. Dai T., Natarajan R., Nast C., LaPage J., Chuang P., Sim J., et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int 69 (2006) 806-814
37. Wada T.A.H., Furuichi K., Sakai N., Kitagawa K., Iwata Y., Matsushima K., et al. Reduction in chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase. Am J Nephrol 26 (2006) 319-325
38. Weigert C., Sauer U., Brodbeck K., Pfeiffer A., Haring H., and Schleicher E.D. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-b1 promoter in mesangial cells. J Am Soc Nephrol 11 (2000) 2007-2016
39. Geiser A.G., Kim S.-J., Roberts A.B., and Sporn M.B. Characterization of the mouse transforming growth factor-b1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 11 (1991) 84-92
40. Suresh B.P., and Srinivasan K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181 (1998) 87-96
41. Sharma S., Kulkarni S.K., and Chopra K. Curcumin, the active principle of turmeric (curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 33 (2006) 940-945
42. Hoffman B., Sharma K., Zhu Y., and Ziyadeh F.N. Transcriptional activation of transforming growth factor-b1 in mesangial cell culture by high glucose concentration. Kidney Int 54 (1998) 1107-1116
43. Zhu Y., Casado M., Vaulont S., and Sharma K. Role of upstream stimulatory factors in regulation of renal transforming growth factor-{beta}1. Diabetes 54 (2005) 1976-1984
44. Weigert C., Brodbeck K., Sawadogo M., Haring H.U., and Schleicher E.D. Upstream stimulatory factor (USF) proteins induce human TGF-{beta}1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279 (2004) 15908-15915
45. In: Miyazano K., and Heldin C.-H. (Eds). Latent forms of TGF-b: molecular structure and mechanisms of activation (1991), Wiley, Chichester, UK 81-92
46. Roberts A.B. TGF-beta signaling from receptors to the nucleus. Microbes Infect 1 (1999) 1265-1273
47. Bottinger E., Factor V., Tsang M., Weatherbee J., Kopp J., Qian S., et al. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A 93 (1996) 5877-5882
48. Nomura K.T.H., Kuboki K., and Inokuchi T. Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells. Nephron 91 (2002) 606-611
49. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130 (1995) 503-506
50. Stenina O.I., Krukovets I., Wang K., Zhou Z., Forudi F., Penn M.S., et al. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation 107 (2003) 3209-3215
51. Wahab N., Schaefer L., Weston B.S., Yiannikouris O., Wright A., Babelova A., et al. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48 (2005) 2650-2660
52. Raugi G., and Lovett D. Thrombospondin secretion by cultured human glomerular mesangial cells. Am J Pathol 129 (1987) 364-372
53. Murphy-Ullrich J.E.S.-C.S., and Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 3 (1992) 181-188
54. Schultz-Cherry S., Chen H., Mosher D.F., Misenheimer T.M., Krutzsch H.C., Roberts D.D., et al. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270 (1995) 7304-7310
55. Ribeiro S., Poczatek M., Schultz-Cherry S., Villain M., and Murphy-Ullrich J.E. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274 (1999) 13586-13593
56. Wang S., Skorczewski J., Feng X., Mei L., and Murphy-Ullrich J.E. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-{beta} activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279 (2004) 34311-34322
57. Weber I., Harrison R., and Iozzo R. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 271 (1996) 31767-31770
58. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-b by the proteoglycan decorin. Nature 346 (1990) 281-284
59. Hildebrand A.R., Rasmussen M., Heinegard L.M., Twardzik D., Border W.A., and Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302 (1994) 527-534
60. Mogyorosi A., and Ziyadeh F.N. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275 (1998) F827-F832
61. Holmes D., Wahab N., and Mason R. Identification of glucose-regulated genes in human mesangial cells by mRNA differential display. Biochem Biophys Res Commun 238 (1997) 179-184
62. Murphy M., Godson C., Cannon S., Kato S., Mackenzie H.S., Martin F., et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274 (1999) 5830-5834
63. Wahab N., Parker S., Sraer J.-D., and Mason R. The decorin high glucose response element and mechanism of its activation in human mesangial cells. J Am Soc Nephrol 11 (2000) 1607-1619
64. Schaefer L., Raslik I., Grone H.-J., Schonherr E., Macakova K., Ugorcakova J., et al. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15 (2001) 559-561
65. Wolf G., Sharma K., Chen Y., Ericksen M., and Ziyadeh F.N. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-b. Kidney Int 42 (1992) 647-656
66. Sharma K., and Ziyadeh F.N. The emerging role of transforming growth factor-b in kidney diseases. Am J Physiol 266 (1994) F829-F842
67. Ziyadeh F.N., Sharma K., Ericksen M., and Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-b. J Clin Invest 93 (1994) 536-542
68. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52 (2003) 2586-2593
69. Usui H., Shikata K., Matsuda M., Okada S., Ogawa D., Yamashita T., et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 18 (2003) 265-272
70. Sassy-Prigent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49 (2000) 466-475
71. Pawluczyk I., and Harris K.P. Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. J Am Soc Nephrol 8 (1997) 1525-1536
72. Wang A., and Hascall V.C. Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 279 (2004) 10279-10285
73. van Berkel TJ O.R., Hoekstra M., Kuiper J., Biessen E., and van Eck M. Scavenger receptors: friend or foe in atherosclerosis?. Curr Opin Lipidol 16 (2005) 525-535
74. Nishida M., Fujinaka H., Matsusaka T., Price J., Kon V., Fogo A.B., et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110 (2002) 1859-1868
75. Oliver J.A. Unexpected news in renal fibrosis. J Clin Invest 110 (2002) 1763-1764
76. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99 (1997) 342-348
77. Wolf G., Chen S., and Ziyadeh F.N. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54 (2005) 1626-1634
78. Steffes M.W., Schmidt D., McCrery R., and Basgen J.M. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59 (2001) 2104-2113
79. van Det N., Verhagen N.A., Tamsma J.T., Berden J.H., Bruijn J.A., Daha M.R., et al. Diabetes. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes 46 (1997) 834-840
80. De La Cruz M.C.I., Ziyadeh F., Isono M., Kouahou M., Han D., Kalluri R., et al. Effects of high glucose and TGF-B1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62 (2002) 1-13
81. Chen S., Kasama Y., Lee J.S., Jim B., Marin M., and Ziyadeh F.N. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 53 (2004) 2939-2949
82. Chen S., Lee J.S., Iglesias-de la Cruz M.C., Wang A., Izquierdo-Lahuerta A., Gandhi N.K., et al. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 20 (2005) 1320-1328
83. Benigni A., Zoja C., Corna D., Zatelli C., Conti S., Campana M., et al. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 14 (2003) 1816-1824
84. Ziyadeh F., Hoffman B., Han D., Iglesias-de la Cruz C., Hong S., Isono M., et al. Long-term prevention of renal insufficiency excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-b antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97 (2000) 8015-8020
85. Chen S., Iglesias-de la Cruz M., Hong S., Isono M., and Ziyadeh F. Reversibility of established diabetic glomerulopathy by anti-TGF-b antibodies in db/db mice. Biochem Biophys Res Commun 300 (2003) 16-22
86. Sharma K., and Ziyadeh F.N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44 (1995) 1139-1146
87. Ziyadeh F.N., and Sharma K. Overview: combating diabetic nephropathy. J Am Soc Nephrol 14 (2003) 1355-1357
88. Del Prato S., and Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 17 (2001) 164-174